These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 30473057

  • 1. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
    Ahmad A, Ali T, Kim MW, Khan A, Jo MH, Rehman SU, Khan MS, Abid NB, Khan M, Ullah R, Jo MG, Kim MO.
    Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits.
    Shah SA, Yoon GH, Chung SS, Abid MN, Kim TH, Lee HY, Kim MO.
    Mol Psychiatry; 2017 Mar; 22(3):407-416. PubMed ID: 27001618
    [Abstract] [Full Text] [Related]

  • 6. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR, Yang HJ, Park KI, Ma JY.
    Phytomedicine; 2019 Mar 01; 55():14-22. PubMed ID: 30668424
    [Abstract] [Full Text] [Related]

  • 7. Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
    Ma C, Wang Z, Xia R, Wei L, Zhang C, Zhang J, Zhao L, Wu H, Kang L, Yang S.
    Biomed Pharmacother; 2021 May 01; 137():111344. PubMed ID: 33581653
    [Abstract] [Full Text] [Related]

  • 8. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.
    Handa P, Maliken BD, Nelson JE, Morgan-Stevenson V, Messner DJ, Dhillon BK, Klintworth HM, Beauchamp M, Yeh MM, Elfers CT, Roth CL, Kowdley KV.
    Hepatology; 2014 Jul 01; 60(1):133-45. PubMed ID: 24464605
    [Abstract] [Full Text] [Related]

  • 9. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K, Ryu D, Dongiovanni P, Ozcan L, Nayak S, Ueberheide B, Valenti L, Auwerx J, Pajvani UB.
    Gastroenterology; 2017 Dec 01; 153(6):1568-1580.e10. PubMed ID: 28859855
    [Abstract] [Full Text] [Related]

  • 10. The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease.
    Yoon G, Shah SA, Ali T, Kim MO.
    Mol Neurobiol; 2018 Aug 01; 55(8):6673-6686. PubMed ID: 29335844
    [Abstract] [Full Text] [Related]

  • 11. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice.
    Zheng Y, Liu T, Wang Z, Xu Y, Zhang Q, Luo D.
    Int J Biol Macromol; 2018 Jun 01; 112():929-936. PubMed ID: 29447962
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
    Deng X, Wang J, Jiao L, Utaipan T, Tuma-Kellner S, Schmitz G, Liebisch G, Stremmel W, Chamulitrat W.
    Biochim Biophys Acta; 2016 May 01; 1861(5):449-61. PubMed ID: 26873633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.
    Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM.
    World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861
    [Abstract] [Full Text] [Related]

  • 18. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
    Goto T, Teraminami A, Lee JY, Ohyama K, Funakoshi K, Kim YI, Hirai S, Uemura T, Yu R, Takahashi N, Kawada T.
    J Nutr Biochem; 2012 Jul 14; 23(7):768-76. PubMed ID: 21889885
    [Abstract] [Full Text] [Related]

  • 19. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.
    Obesity (Silver Spring); 2010 Apr 14; 18(4):780-7. PubMed ID: 19798065
    [Abstract] [Full Text] [Related]

  • 20. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.
    Xin XM, Zhong MX, Yang GL, Peng Y, Zhang YL, Zhu W.
    World J Gastroenterol; 2014 Nov 14; 20(42):15727-35. PubMed ID: 25400456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.